Page 134 - Read Online

Page 24 of 25 Luo et al. Microbiome Res Rep 2025;4:10 https://dx.doi.org/10.20517/mrr.2024.57

154. Anisimova E, Gorokhova I, Karimullina G, Yarullina D. Alarming antibiotic resistance of Lactobacilli isolated from probiotic
preparations and dietary supplements. Antibiotics 2022;11:1557. DOI PubMed PMC
155. Castro CP, Drumond MM, Batista VL, Nunes A, Mancha-Agresti P, Azevedo V. Vector development timeline for mucosal
vaccination and treatment of disease using Lactococcus lactis and design approaches of next generation food grade plasmids. Front
Microbiol 2018;9:1805. DOI PubMed PMC
156. Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human
diseases. Nat Commun 2020;11:1738. DOI PubMed PMC
157. Yan X, Liu X, Zhao C, Chen GQ. Applications of synthetic biology in medical and pharmaceutical fields. Signal Transduct Target
Ther 2023;8:199. DOI PubMed PMC
158. Gibson DG, Glass JI, Lartigue C, et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science
2010;329:52-6. DOI
159. Sung BH, Choe D, Kim SC, Cho BK. Construction of a minimal genome as a chassis for synthetic biology. Essays Biochem
2016;60:337-46. DOI
160. Calero P, Nikel PI. Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional
microorganisms. Microb Biotechnol 2019;12:98-124. DOI PubMed PMC
161. Zhu D, Fu Y, Liu F, Xu H, Saris PE, Qiao M. Enhanced heterologous protein productivity by genome reduction in Lactococcus lactis
NZ9000. Microb Cell Fact 2017;16:1. DOI PubMed PMC
162. Hille F, Richter H, Wong SP, Bratovič M, Ressel S, Charpentier E. The biology of CRISPR-Cas: backward and forward. Cell
2018;172:1239-59. DOI PubMed
163. Hryhorowicz M, Lipiński D, Zeyland J, Słomski R. CRISPR/Cas9 immune system as a tool for genome engineering. Arch Immunol
Ther Exp 2017;65:233-40. DOI PubMed PMC
164. Xiao Y, Ng S, Nam KH, Ke A. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration. Nature
2017;550:137-41. DOI PubMed PMC
165. Kleinstiver BP, Prew MS, Tsai SQ, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 2015;523:481-
5. DOI PubMed PMC
166. Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat Rev Genet 2014;15:321-34. DOI PubMed
167. Gaj T, Gersbach CA, Barbas CF 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol
2013;31:397-405. DOI PubMed PMC
168. Ren J, Lee J, Na D. Recent advances in genetic engineering tools based on synthetic biology. J Microbiol 2020;58:1-10. DOI
169. Gaudelli NM, Komor AC, Rees HA, et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nature 2017;551:464-71. DOI PubMed PMC
170. Anzalone AV, Randolph PB, Davis JR, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature
2019;576:149-57. DOI PubMed PMC
171. Peters JE, Craig NL. Tn7: smarter than we thought. Nat Rev Mol Cell Biol 2001;2:806-14. DOI PubMed
172. Crawley AB, Henriksen ED, Stout E, Brandt K, Barrangou R. Characterizing the activity of abundant, diverse and active CRISPR-
Cas systems in lactobacilli. Sci Rep 2018;8:11544. DOI PubMed PMC
173. Pan M, Morovic W, Hidalgo-Cantabrana C, et al. Genomic and epigenetic landscapes drive CRISPR-based genome editing in
Bifidobacterium. Proc Natl Acad Sci U S A 2022;119:e2205068119. DOI PubMed PMC
174. Song X, Huang H, Xiong Z, Ai L, Yang S. CRISPR-Cas9 D10A Nickase-assisted genome editing in Lactobacillus casei. Appl Environ
Microbiol 2017;83:e01259-17. DOI PubMed PMC
175. Myrbråten IS, Wiull K, Salehian Z, et al. CRISPR interference for rapid knockdown of essential cell cycle genes in Lactobacillus
plantarum. mSphere 2019;4:e00007-19. DOI PubMed PMC
176. Hidalgo-Cantabrana C, Goh YJ, Pan M, Sanozky-Dawes R, Barrangou R. Genome editing using the endogenous type I CRISPR-Cas
system in Lactobacillus crispatus. Proc Natl Acad Sci U S A 2019;116:15774-83. DOI PubMed PMC
177. Han X, Chang L, Chen H, et al. Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in Bifidobacterium
breve. Appl Environ Microbiol 2024;90:e0207423. DOI PubMed PMC
178. Ninyio N, Schmitt K, Sergon G, Nilsson C, Andersson S, Scherbak N. Stable expression of HIV-1 MPER extended epitope on the
surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9. Microb Cell Fact 2024;23:39. DOI
PubMed PMC
179. Zhou Y, Song F, Yang H, et al. Construction of a food-grade gene editing system based on CRISPR-Cas9 and its application in
Lactococcus lactis NZ9000. Biotechnol Lett 2023;45:955-66. DOI
180. Yu J, Zhou B, Zhang S, et al. Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy.
Nat Commun 2022;13:7903. DOI PubMed PMC
181. Tian X, Liu X, Zhang Y, et al. Metabolic engineering coupled with adaptive evolution strategies for the efficient production of high-
quality L-lactic acid by Lactobacillus paracasei. Bioresour Technol 2021;323:124549. DOI
182. Oh JH, van Pijkeren JP. CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res 2014;42:e131. DOI
PubMed PMC
183. Fang M, Zhang R, Wang C, et al. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic
resistance genes by exploiting a type I CRISPR-Cas system. Appl Environ Microbiol 2024;90:e0081124. DOI PubMed